257 related articles for article (PubMed ID: 35720420)
21. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
22. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
[TBL] [Abstract][Full Text] [Related]
23. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
25. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF-β1/SMAD4 expression.
Chen MJ; Wang YC; Wang L; Shen CJ; Chen CY; Lee H
Thorac Cancer; 2022 May; 13(9):1322-1332. PubMed ID: 35373505
[TBL] [Abstract][Full Text] [Related]
27. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
28. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
Chen Q; Han B; Meng X; Duan C; Yang C; Wu Z; Magafurov D; Zhao S; Safin S; Jiang C; Cai J
Int J Cancer; 2019 Jul; 145(2):517-530. PubMed ID: 30613962
[TBL] [Abstract][Full Text] [Related]
29. CCR7 Mediates TGF-β1-Induced Human Malignant Glioma Invasion, Migration, and Epithelial-Mesenchymal Transition by Activating MMP2/9 Through the Nuclear Factor KappaB Signaling Pathway.
Zheng Y; Miu Y; Yang X; Yang X; Zhu M
DNA Cell Biol; 2017 Oct; 36(10):853-861. PubMed ID: 28817313
[TBL] [Abstract][Full Text] [Related]
30. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
[TBL] [Abstract][Full Text] [Related]
31. Biological Role and Therapeutic Targeting of TGF-β
Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
[TBL] [Abstract][Full Text] [Related]
32. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.
Wang H; Wu Q; Zhang Y; Zhang HN; Wang YB; Wang W
Cell Mol Biol Lett; 2017; 22():22. PubMed ID: 29118814
[TBL] [Abstract][Full Text] [Related]
33. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
34. Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
Anderson HG; Takacs GP; Harris DC; Kuang Y; Harrison JK; Stepien TL
J Math Biol; 2023 Dec; 88(1):10. PubMed ID: 38099947
[TBL] [Abstract][Full Text] [Related]
35. A pan-cancer analysis of the FAT1 in human tumors.
Wang Z; Lin K; Xiao H
Sci Rep; 2022 Dec; 12(1):21598. PubMed ID: 36517565
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
37. Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma.
Cao JY; Guo Q; Guan GF; Zhu C; Zou CY; Zhang LY; Cheng W; Wang GL; Cheng P; Wu AH; Li GY
Aging (Albany NY); 2020 Jan; 12(2):1656-1684. PubMed ID: 32003759
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
Ye XZ; Xu SL; Xin YH; Yu SC; Ping YF; Chen L; Xiao HL; Wang B; Yi L; Wang QL; Jiang XF; Yang L; Zhang P; Qian C; Cui YH; Zhang X; Bian XW
J Immunol; 2012 Jul; 189(1):444-53. PubMed ID: 22664874
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
Liu H; Chen C; Zeng J; Zhao Z; Hu Q
PLoS One; 2021; 16(7):e0253522. PubMed ID: 34197482
[TBL] [Abstract][Full Text] [Related]
40. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.
Lohr J; Ratliff T; Huppertz A; Ge Y; Dictus C; Ahmadi R; Grau S; Hiraoka N; Eckstein V; Ecker RC; Korff T; von Deimling A; Unterberg A; Beckhove P; Herold-Mende C
Clin Cancer Res; 2011 Jul; 17(13):4296-308. PubMed ID: 21478334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]